908 Devices Lifts Low End of 2026 Outlook as Q2 Revenue Climbs 23%
MASS sits 73% above its 52-week low of $5.025.
Summary
908 Devices posted Q2 2026 revenue of $16.1 million, up 23% year-over-year, and raised the low end of its full-year revenue guidance to $68 million. The adjusted EBITDA loss narrowed significantly, and the quarter ended with $101.5 million in cash.
Key Events · Earnings and Guidance · MASS
-
Q2 Revenue Beats, Up 23%
Revenue reached $16.1 million, driven by VipIR product sales and the addition of NIRLab revenue. Recurring revenue was $4.9 million, or 31% of total.
-
Adjusted EBITDA Loss Narrows
Adjusted EBITDA loss improved to $1.9 million from $3.9 million a year ago, reflecting higher revenue and cost discipline.
-
Full-Year Guidance Raised
2026 revenue outlook raised to $68M-$70M (from $67M-$70M), implying 21%-25% growth. The raise reflects confidence in second-half demand.
-
Strong Balance Sheet
Cash and equivalents stood at $101.5 million with no debt, providing ample runway for growth investments.
Analysis · MASS · Industrial Applications And Services
A 23% year-over-year revenue jump to $16.1 million and a more than halved adjusted EBITDA loss highlight a strong quarter for 908 Devices. The company raised the low end of its full-year revenue guidance, now projecting $68 million to $70 million, which implies 21% to 25% growth. With $101.5 million in cash and no debt, the balance sheet remains solid. While GAAP profitability is still elusive, the results and guidance raise point to improving operational momentum.
At the time of this filing, MASS was trading at $8.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $361M. The 52-week trading range was $5.03 to $9.34. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.